ALK and non-small cell lung carcinoma: As RNA-based assays were reported as promising tools for ALK testing in some case series [24–27], we performed massive parallel sequencing (MPS) using IonTorrent chemistry and a probe-based technology (NanoString) allowing a direct counting of RNA molecules in an IHC and FISH pretested NSCLC cohort [13, 21].